Matterworks, Inc.

Matterworks, Inc. is a biotechnology company pioneering the development of advanced artificial intelligence tools designed to accelerate discovery and development within the life sciences sector. Founded in 2019 and headquartered in Somerville, Massachusetts, the company focuses on unlocking the vast potential of biological data through its proprietary AI-driven platform. Matterworks aims to democratize metabolomics—the study of small molecules within cells—by overcoming the traditional bottlenecks associated with data acquisition and interpretation. Their technology leverages deep learning to provide real-time, quantitative insights into biological systems, enabling researchers to characterize diverse chemical classes with unprecedented speed and accuracy.

The company's flagship product, Pyxis™, is an AI-powered platform that automates the identification and absolute quantitation of analytes from mass spectrometry data. By productizing self-supervised machine intelligence, Matterworks allows scientists to bypass weeks of manual method development and calibration, delivering results in minutes. This transformative approach supports a wide range of applications, including therapeutic research, biomanufacturing, and drug development. Matterworks is dedicated to building a future where complex biological data is easily accessible and actionable, ultimately driving faster scientific progress and more efficient development of life-saving therapies.